Back to Results
First PageMeta Content
Biology / Drugs in sport / Anemias / Amgen / Erythropoietin / Darbepoetin alfa / Anemia / Medicare / Medicine / Erythropoiesis-stimulating agents / Growth factors


Comparison of compliance and efficacy between EPO and DP0 treatments in the Medicare dialysis population Shu-Cheng Chen1, James P. Ebben1, Diane Frankenfield2, Penny Mohr2, and Allan J. Collins1 1United States Renal Data
Add to Reading List

Document Date: 2007-11-07 11:03:38


Open Document

File Size: 103,94 KB

Share Result on Facebook

Company

EPO / /

MedicalCondition

similar anemia / hypertension / single chronic treatment / EPOand DPO-treated ESRD / end-stage renal disease / ESRD / anemia / diabetes / /

MedicalTreatment

dialysis / /

Organization

Minneapolis Medical Research Foundation / Medicare / /

/

Position

Hb / achieved Hb / mean monthly Hb / average monthly Hb / recommended upper target Hb / monthly Hb / established Hb / /

Technology

ESA / dialysis / /

SocialTag